Back to MORGAN STANLEY MORGAN STANLEY

RAPPRAPP
8 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in RAPPORT THERAPEUTICS INC

MORGAN STANLEY holds 297,612 shares of RAPP (RAPPORT THERAPEUTICS INC), worth $12.4M as of 2026-Q2. The position was increased (+79.3% shares). RAPP represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$12.4M

Current Shares

297,612

Total Value Change

+$11.9M

Total Shares Change

+273,384

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
297,612
+79.3%
$12.4M0.0%$41.67
43
2026-Q1
Decreased
165,954
-21.1%
$5.2M0.0%$27.85
0
2025-Q4
Decreased
210,331
-23.4%
$6.4M0.0%$30.64
0
2025-Q3
Increased
274,568
+295.3%
$8.2M0.0%$27.97
44
2025-Q2
Decreased
69,463
-9.3%
$789,7930.0%$11.43
0
2025-Q1
Increased
76,604
+238.4%
$768,3380.0%$10.05
40
2024-Q4
Decreased
22,636
-6.6%
$401,5620.0%$18.49
0
2024-Q3
New
24,228
-
$496,1890.0%$21.33
37

Other major holders of RAPP: FMR LLC, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used